The latest price target for Rapid Micro Biosystems (NASDAQ:RPID) was reported by Morgan Stanley on March 7, 2023. The analyst firm set a price target for $2.75 expecting RPID to rise to within 12 months (a possible 168.79% upside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for Rapid Micro Biosystems (NASDAQ:RPID) was provided by Morgan Stanley, and Rapid Micro Biosystems reiterated their equal-weight rating.

There is no last upgrade for Rapid Micro Biosystems

The last downgrade for Rapid Micro Biosystems Inc happened on August 16, 2022 when JP Morgan changed their price target from N/A to N/A for Rapid Micro Biosystems Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rapid Micro Biosystems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rapid Micro Biosystems was filed on March 7, 2023 so you should expect the next rating to be made available sometime around March 7, 2024.

While ratings are subjective and will change, the latest Rapid Micro Biosystems (RPID) rating was a reiterated with a price target of $0.00 to $2.75. The current price Rapid Micro Biosystems (RPID) is trading at is $1.02, which is within the analyst’s predicted range.